Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency.

Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP.

J Clin Endocrinol Metab. 2002 Jul;87(7):3031-7.

PMID:
12107196
2.

Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.

Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP.

J Clin Endocrinol Metab. 2002 May;87(5):2114-20.

PMID:
11994350
3.

Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia.

Verma S, Green-Golan L, VanRyzin C, Drinkard B, Mehta SP, Weise M, Eisenhofer G, Merke DP.

Horm Metab Res. 2010 Jul;42(8):607-12. doi: 10.1055/s-0030-1253385. Epub 2010 May 5.

PMID:
20446239
4.

Evaluation of adrenomedullary function in patients with congenital adrenal hyperplasia.

Tutunculer F, Saka N, Arkaya SC, Abbasoglu S, Bas F.

Horm Res. 2009;72(6):331-6. doi: 10.1159/000249160. Epub 2009 Oct 21.

PMID:
19844121
5.

Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.

Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR.

N Engl J Med. 2000 Nov 9;343(19):1362-8.

6.

Congenital adrenal hyperplasia and the function of adrenal medulla.

Lisá L, Bílek R, Vrzalová Z.

Horm Mol Biol Clin Investig. 2010 Aug 1;2(2):245-8. doi: 10.1515/HMBCI.2010.030.

PMID:
25961196
7.

Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management.

Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-Fékété C, Morel Y, Brauner R.

J Clin Endocrinol Metab. 2003 Jun;88(6):2624-33.

PMID:
12788866
8.

Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.

Krone N, Rose IT, Willis DS, Hodson J, Wild SH, Doherty EJ, Hahner S, Parajes S, Stimson RH, Han TS, Carroll PV, Conway GS, Walker BR, MacDonald F, Ross RJ, Arlt W; United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).

J Clin Endocrinol Metab. 2013 Feb;98(2):E346-54. doi: 10.1210/jc.2012-3343. Epub 2013 Jan 21.

9.

Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency.

Speiser PW.

J Clin Endocrinol Metab. 2002 Jul;87(7):3029-30. No abstract available.

PMID:
12107195
10.

Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Völkl TM, Simm D, Beier C, Dörr HG.

Pediatrics. 2006 Jan;117(1):e98-105.

PMID:
16396852
11.

Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP.

J Clin Endocrinol Metab. 2000 Mar;85(3):1059-65.

PMID:
10720040
12.

[Congenital adrenal hyperplasia].

Stanić M, Nesović M.

Med Pregl. 1999 Nov-Dec;52(11-12):447-54. Review. Croatian.

PMID:
10748766
13.

Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.

Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.

J Clin Endocrinol Metab. 2002 May;87(5):2238-44.

PMID:
11994370
14.

[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].

Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.

Endokrynol Pol. 2010;61 Suppl 1:7-21. Polish.

PMID:
22127631
15.

[Multicentric study of Brazilian patients with 21-hydroxylase deficiency: a genotype-phenotype correlation].

Bachega TA, Billerbeck AE, Parente EB, Lemos-Marini SH, Baptista MT, Mello MP, Guerra G Jr, Kuperman H, Setian N, Damiani D, Torres N, Castro Md, Mendonça BB.

Arq Bras Endocrinol Metabol. 2004 Oct;48(5):697-704. Epub 2005 Mar 7. Review. Portuguese.

16.

Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.

Pasqualini T, Alonso G, Tomasini R, Galich AM, Buzzalino N, Fernandez C, Minutolo C, Alba L, Dain L.

Medicina (B Aires). 2007;67(3):253-61.

PMID:
17628913
17.

Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia.

Kim MS, Ryabets-Lienhard A, Bali B, Lane CJ, Park AH, Hall S, Geffner ME.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1597-601. doi: 10.1210/jc.2014-1274. Epub 2014 May 30.

18.

Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.

Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.

J Clin Endocrinol Metab. 2007 May;92(5):1635-9. Epub 2007 Feb 13.

PMID:
17299071
19.

NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Merke DP, Bornstein SR, Avila NA, Chrousos GP.

Ann Intern Med. 2002 Feb 19;136(4):320-34. Review.

PMID:
11848730
20.

Supplemental Content

Support Center